Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation

Ann Lab Med. 2017 Jan;37(1):45-52. doi: 10.3343/alm.2017.37.1.45.

Abstract

Background: The interaction between killer immunoglobulin-like receptors (KIRs) and HLA class I regulates natural killer (NK) cell cytotoxicity and function. The impact of NK cell alloreactivity through KIR in liver transplantation remains unelucidated. Since the frequency of HLA-C and KIR genotypes show ethnic differences, we assessed the impact of HLA-C, KIR genotype, or KIR-ligand mismatch on the allograft outcome of Korean liver allografts.

Methods: One hundred eighty-two living donor liver transplant patients were studied. Thirty-five patients (19.2%) had biopsy-confirmed acute rejection (AR), and eighteen (9.9%) had graft failure. The HLA-C compatibility, KIR genotypes, ligand-ligand, and KIR-ligand matching was retrospectively investigated for association with allograft outcomes.

Results: Homozygous C1 ligands were predominant in both patients and donors, and frequency of the HLA-C2 allele in Koreans was lower than that in other ethnic groups. Despite the significantly lower frequency of the HLA-C2 genotype in Koreans, donors with at least one HLA-C2 allele showed higher rates of AR than donors with no HLA-C2 alleles (29.2% vs 15.7%, P=0.0423). Although KIR genotypes also showed ethnic differences, KIR genotypes and the number of activating KIR/inhibitory KIR were not associated with the allograft outcome. KIR-ligand mismatch was expected in 31.6% of Korean liver transplants and had no impact on AR or graft survival.

Conclusions: This study could not confirm the clinical impact of KIR genotypes and KIR-ligand mismatch. However, we demonstrated that the presence of HLA-C2 allele in the donor influenced AR of Korean liver allografts.

Keywords: Allograft outcome; HLA-C; KIR-ligand mismatch; Killer immunoglobulin-like receptors; Liver transplantation.

MeSH terms

  • Adult
  • Alleles
  • Asian People / genetics*
  • Female
  • Genotype
  • Graft Rejection
  • Graft Survival
  • HLA-C Antigens / genetics*
  • Homozygote
  • Humans
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / immunology
  • Ligands
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Receptors, KIR / chemistry
  • Receptors, KIR / genetics*
  • Receptors, KIR / metabolism
  • Republic of Korea
  • Tissue Donors
  • Transplantation, Homologous

Substances

  • HLA-C Antigens
  • Ligands
  • Receptors, KIR